Cannabinoid hyperemesis syndrome (CHS) is more common than most people think. Among daily cannabis users, roughly 1 in 6 (17.8%) report CHS-like symptoms of severe nausea, vomiting, or abdominal pain. That translates to an estimated 7.2 million U.S. adults, giving CHS a national prevalence of about 2.7% across the general population.
Those numbers surprise many people because CHS was considered rare until recently. The condition was first described in 2004, and for years it was treated as a medical curiosity. That perception has changed dramatically as cannabis use, potency, and legalization have expanded.
CHS Cases Are Rising Fast
Emergency department visits for CHS have climbed sharply over the past decade. In Ontario, Canada, monthly ER visit rates for the condition increased 13-fold between January 2014 and June 2021, going from 0.26 visits per 100,000 people to 3.43 per 100,000. Interestingly, legalization of recreational cannabis alone didn’t cause an immediate spike. The sharper jump came later, when commercial cannabis retail expanded during the COVID-19 pandemic period, which was associated with a 49% increase in CHS-related ER visits.
This pattern suggests that what drives CHS rates isn’t legality itself but access, frequency of use, and the potency of available products. As concentrates, edibles, and high-THC flower have become more widely available, more people are using cannabis daily or near-daily, which is the primary risk factor.
Who Gets CHS
CHS skews young. The average age at diagnosis is about 31, and two-thirds of patients fall between 18 and 35. A large U.S. study covering 2016 to 2022 found that 35.7% of CHS patients were 18 to 25, with another 31.5% in the 26 to 35 range. The gender split is nearly even, with about 50.8% of cases occurring in women, which sets CHS apart from cannabis use disorder overall (which is more common in men) and cyclic vomiting syndrome (which leans female).
The typical CHS patient has been using cannabis regularly for years before symptoms appear. There’s no single threshold for how much or how long you need to use before it develops, but daily or near-daily use is the consistent pattern in diagnosed cases.
Why CHS Is Underdiagnosed
The 17.8% figure among daily users likely captures people who haven’t been formally diagnosed yet, and that’s a significant detail. CHS is frequently mistaken for other conditions, particularly cyclic vomiting syndrome (CVS), which looks almost identical on the surface. In one study, a third of patients were diagnosed with CHS based only on marijuana use and uncontrollable vomiting, without thorough workup. Making matters harder, up to 10% of CHS patients don’t show the classic “compulsive hot shower” behavior that many clinicians rely on as a clue. And nearly half of CVS patients take hot showers too, muddying the distinction further.
Many people with CHS cycle through multiple ER visits, imaging studies, and specialist referrals before getting the correct diagnosis. If you use cannabis regularly and experience recurring episodes of intense nausea and vomiting that standard treatments don’t resolve, CHS is worth considering even if a doctor hasn’t brought it up.
Why Hot Showers Help (Temporarily)
One of the hallmark behaviors of CHS is spending hours in a hot shower or bath during episodes. This isn’t psychological. Chronic cannabis use appears to disrupt the body’s internal signaling system that cannabinoids normally regulate. Hot water activates pain and heat receptors in the skin (the same ones that respond to chili peppers), and stimulating these receptors triggers a cascade of chemical signals that temporarily suppress nausea. Capsaicin cream applied to the abdomen works through the same mechanism, which is why some emergency departments now use it as a treatment during acute episodes.
The relief is real but temporary. It doesn’t address the underlying problem, which is that chronic cannabis exposure has pushed the body’s cannabinoid system into a dysfunctional state.
How Long Recovery Takes
The only proven way to resolve CHS is to stop using cannabis entirely. Most clinical guidance looks for at least six months of complete abstinence to confirm the diagnosis and allow full symptom resolution. In practice, the timeline varies widely. Some people feel significantly better within weeks of quitting, while full recovery from both the vomiting syndrome and the underlying cannabis use pattern can take anywhere from 3 months to 4 years.
Symptoms reliably return if cannabis use resumes, even after long periods of abstinence. This is one of the defining features that separates CHS from other vomiting disorders. For people who’ve experienced multiple episodes, even occasional use carries a high risk of triggering a relapse.
The Bottom Line on Rarity
CHS is not rare. It was once thought to be because cannabis research was limited, diagnostic awareness was low, and fewer people used cannabis daily. With nearly 18% of daily users reporting symptoms consistent with the condition, CHS is one of the more common consequences of heavy cannabis use. The gap between that number and the much smaller fraction of people who receive a formal diagnosis points to a condition that remains significantly underrecognized, both by the people experiencing it and by the clinicians treating them.